| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 2.1 | 53.5 | 15.9 |
| Total income | 2.1 | 53.5 | 15.9 |
| Profit before exceptional items & tax | 0.2 | 1.4 | 0.7 |
| Profit before tax | 0.2 | 1.4 | 0.7 |
| Net profit | 0.2 | 1.0 | 0.5 |
| Operating margin | 9.5% | 2.6% | 4.4% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -60.00% |
|---|---|
| Net profit, quarter on quarter | -80.00% |
| Revenue, year on year | -86.80% |
Source
Read the filing ↗
BSE results filing, BSE: 543594. Figures extracted from the filing.
Dipna Pharmachem Ltd: key numbers
- Share price
- ₹4.73
- Market cap
- ₹12.43 Cr
- Revenue (annual)
- ₹129.1 Cr
- Net profit (annual)
- ₹2.63 Cr
- P/E (TTM)
- 4.7×Sector 50.4×
- Promoter holding
- 9.13%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.